Afsaneh Gray is a freelance science journalist based in London
As researchers around the globe drop everything to find a treatment for COVID-19, we look at the likely frontrunners for managing this deadly disease.
Going against type: the new class of cancer therapies targeting mutations rather than tissuesSubscription
‘Tumour agnostic’ drugs offer a more effective and tolerable therapy for a wide range of people with cancer, so why has the NHS rejected its first one?
Multiple myeloma: an expensive revolutionSubscription
New treatments for this rare form of cancer have transformed patient survival rates, but the benefits have come with huge costs.
Health anxiety: currently trendingSubscription